odin.ces.edu.coodin.ces.edu.co/contenidos_web/41025177.pdf · 2009-04-23 · eric s. rovner, lean...
Post on 29-Aug-2018
213 Views
Preview:
TRANSCRIPT
Contributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .xiii
Foreword xxvii
Foreword to the First Edition. . . . . . . . . . . . . . . . . . . . . . . xxix
Preface.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxxi
SECTION1
Foundation Issues
Sedion Editor:L. Michael Posey
1. Pharmacoeconomics: PrincipIes, Methods,and Applications &..........................Lisa A. Sanchez
2. Health Outcomes and Quality of Life 6). . . . . . . .. 3
Stephen Joel Coons
3. Evidence-BasedMedicine CID 5
Elaine Chiquette and L. Michael Posey
4. Documentation of Pharmacy Services & . . . . . . .. 7George E. MacKinnon, III and Neil /. MacKinnon
5. Clinical Pharmacokinetics
and Pharmacodynamics . . . . . . . . . . . . . . . . . . . . . .. 9
LarryA. Bauer
6. Pharmacogenetics 31Larisa H. Cavallari and Y. W. Prancis Lam
7. Pediatrics 47
Milap C. Nahata and Carol Taketomo
8. Geriatrics 57
Catherine 1. Starner, Shelly L. Gray, David R. P. Guay,Emily R. Hajjar, Steven M. Handler,
and Joseph T. Hanlon
9. Pharmacoepidemiology 6) . . . . . . . . . . . . . . . . . . . 67
Andy Stergachis, Thomas K. Hazlet,and Denise Boudreau
10. ClinicalToxicology . . . . . . . . . . . . . . . . . . . . . . . . .. 69
PeterA. Chyka
\
11. Emergency Preparedness: Identification andManagement of BiologicalExposures (\) 91Colleen M. Terriff, Jason E. Brouillard,
Lisa T. Costanigro, and Jessica S. Gruber
12. Emergency Preparedness: Identificationand Management of Chemical andRadiological Exposures 93Greene Shepherd and Richard B. Schwartz
SECTION 2
Cardiovascular Disorders
SedionEditor:RobertL.Talbert
13. Cardiovascular Testing . . . . . . . . . . . . . . . . . . . . . . .95Robert Chilton and RobertL. Talbert
14. Cardiopulmonary Arrest . . . . . . . . . . . . . . . . . . . . . 123
JeffreyP. Barletta and leffrey L. Wi/t
1 5. Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . 139
loseph l. Saseen and Eric /. MacLaughlin
16. Heart Failure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Robert B. Parker, lo E. Rodgers, and Larisa H. Cavallari
1 7. Ischemic Heart Disease . . . . . . . . . . . . . . . . . . . . . . 217
Robert L. Talbert
18. Acute Coronary Syndromes . . . . . . . . . . . . . . . . . . 249
Sarah A. Spinler and Simon de Denus
19. The Arrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . . . 279
Cynthia A. Sanoski,Marieke Dekker Schoen,and lerry L. Bauman
20. Diastolic Heart Failure
and the Cardiomyopathies ... . . . . . . . . . . . . . . . .315
lean M. Nappi and Robert L. Page, 1I
21. Venous Thromboembolism 331
Stuart T. Haines, Daniel M. Witt, and Edith A. Nutescu
22. Stroke 373
Susan C. Pagan and David C. Hess
\.9 Thecomplete chapter,learningobjectives,and other resourcescan be found at www.pharmacotherapyonline.com.
23. Hyperlipidemia 385Robert L. Talbert
24. Peripheral Arterial Disease . . . . . . . . . . . . . . . . . . . 409
Barbaral. Hoeben and Robert L. Talbert
25. Use ofVasopressors and Inotropes
in the Pharmacotherapy of Shock. . . . . . . . . . . . .417Robert MacLaren, Maria 1. Rudis, and loseph F. Dasta
26. Hypovolemic Shock .441Brian L. Erstad
SECTION 3
RespiratoryDisordersSedion Editor: Robert L. Tolbert
27. Introduction to Pulmonary Function Testing. . . .455
lay 1. Peters and Stephanie M. Levine
28. Asthma 463
H. William Kelly and Christine A. Sorkness
29. Chronic Obstructive Pulmonary Disease. . . . . . . .495
Dennis M. Williams and Sharya V. Bourdet
30. Pulmonary Hypertension . 519
Robert L. Talbert, Rebecca Boudreaux, and Rebecca L. Owens
31. Drug-Induced Pulmonary Diseases . . . . . . . . . . . . 521
Hengameh H. Raissy,MichelleHarkins,and PatriciaL. Marshik
32. Cystic Fibrosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 535
Gary Milavetz
SECTION 4
Gastrointestinal Disorders
Sedion Editor: Joseph T. DiPiro
33. Evaluation of the Gastrointestinal Tract . . . . . . . .547Keith M. Olsen, Marie A. Chisholm, and Mark W. lackson
34. Gastroesophageal Reflux Disease . . . . . . . . . . . . . . 555
Dianne B. Williams and Robert R. Schade
35. Peptic Ulcer Disease. . . . . . . . . . . . . . . . . . . . . . . . . 569
RosemaryR. Berardiand Lynda S. Welage
36. Inflammatory BowelDisease. . . . . . . . . . . . . . . . . . 589
Brian A. Hemstreet and loseph T. DiPiro
37. Nausea and Vomiting .. .. .. .. .. . .. . .. . .. .. .. 607
Cecily V. DiPiro
38. Diarrhea, Constipation, and IrritableBowel Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . .. 617
William l. Spruill and William E. Wade
39. Portal Hypertension and Cirrhosis . . . . . . . . . . .. 633
lulie M. Sease, Edward G. Timm,
and lames l. Stragand
40. Drug-Induced Liver Disease. . . . . . . . . . . . . . . . .. 651
William R. Kirchain and Rondall E. Allen
41. Pancreatitis 659
Rosemary R. Berardi and Patricia A. Montgomery
42. ViralHepatitis. . . .. . . . . . .. . . . . . . . . .. . .. . . . . 675
Paulina Deming
43. Drug Therapy Individualization in Patientswith HepaticDiseaseor GeneticAlterationsin Drug Metabolizing Activity. . . . .. . . . . . .. . .. 693Y.W.FrancisLam
SECTION 5
Renal Disorders
SedionEditor:GaryR.Matzke
44. Quantification of Renal Function . . . . . . . . . . . .. 705
ThomasC.Dowling
45. Acute Renal Failure. . . . . . . . . . . . . . . . . . . . . . . .. 723
William DagerandAnneP.Spencer
46. Chronic Kidney Disease:
Progression-Modifying Therapies. . . . . . . . . . . .. 745
Melanie S. loy, Abhijit Kshirsagar,and Nora Franceschini
47. Chronic Kidney Disease:Management of Complications . . . . . . . . . . . . . .. 765
loanna Q. Hudson
48. Hemodialysisand PeritonealDialysis.. . . . . . .. 793Edward F. Foote and Harold l. Manley
49. Drug-Induced Kidney Disease. . . . . . . . . . . . . . .. 795
Thomas D. Nolin and lonathan Himmelfarb
50. Glomerulonephritis 811Alan H. Lau
51. Drug Therapy Individualization forPatients with Renal Insufficiency. . . . . .. . . . .. .. 833
GaryR.Matzke andReginaldF.Frye
52. Disorders of Sodium and Water Homeostasis. .. 845
lames D. Coyleand Melanie S. loy
(.9 The complete chapter, learningobjectives,and other resourcescan be found at www.pharmacotherapyonline.com.
53. Disorders of Calcium and
Phosphorus Homeostasis . . . . . . . . . . . . . . . . . . .. 861
Amy BartonPai, Mark Rohrscheib,and Melanie S.Joy
54. Disorders of Potassium and
Magnesium Homeostasis . . . . . . . . . . . . . . . . . . .. 877
DonaldF. Brophyand Todd W. B. Gehr
55. Acid-Base Disorders . . . . . . . . . . . . . . . . . . . . . . .. 889
John W. Devlin, Gary R. Matzke, and Paul M. Palevsky
SECTION6
Neurologic OisordersSedionEditor:Barbaro C. Wel/s
56. Evaluation of Neurologic Illness . . . . . . . . . . . . .. 909
Susan C. Fagan and Fenwick T. Nichols
57. Multiple Sclerosis 913
Jacquelyn L. Bainbridge and John R. Corboy
58. Epilepsy 927
Susan]. Rogersand JoseE. Cavazos
59. Status Epilepticus. . . . . . . . . . . . . . . . . . . . . . . . . . . 953
Stephanie]. Phelps,CollinA. Hovinga,and JamesW. Wheless
60. AcuteManagement of the Brain Injury Patient . . .965
Bradley A. Boucher and Shelly D. Timmons
61. Parkinson' s Disease. . . . . . . . . . . . . . . . . . . . . . . .. 977
Jack]. Chen, Merlin V. Nelson, and David M. Swope
62. Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . 989
Terry ]. Baumann and Jennifer Strickland
63. Headache Disorders . . . . . . . . . . .. 1005
Deborah S. Minor and Marion R. Wofford
SECTION7
Psychiatric OisordersSedionEditor:Barbaro C. Wel/s
64. Evaluation of Psychiatric Illness .. . . . . . . . . . .. 1021Patricia A. Marken, Mark E. Schneiderhan,and Stuart Munro
65. Childhood Disorders. . . . . . . . . . . . . . . . . . . . . .. 1029
Julie Ann Dopheide, Jane Tran Tesoro, and Michael Malkin
66. Eating Disorders. . .. . . . . . .. . . . . . .. . . . . . .. . . 1041
Steven C. Stoner
67. Alzheimer' s Disease . . . . . . . . . . . . . . . . . . . . . . . . 1051
Patricia W. Slattum, Russell H. Swerdlow,
and Angela Massey Hill
68. Substance-Related Disorders: Overview and
Depressants, Stimulants, and Hallucinogens. . . . 1067Paul L. Doering and Lisa A. Boothby
69. Substance- Related Disorders: Alcohol,
Nicotine, and Caffeine. . . . . . . . . . . . . . . . . . . . . . 1083
Paul L. Doering, W. Klugh Kennedy, and LisaA. Boothby
70. Schizophrenia 1099
M. Lynn Crismon, Tami R. Argo, and Peter F. Buckley
71. Depressive Disorders . . . . . . . . . . . . . . . . . . . . . . . 1123
ChristianJ. Teter, Judith C. Kando, Barbara G. Wells,
and Peggy E.Hayes
72. Bipolar Disorder. . . . . . . . . . . . . . . . . . . . . . . . . . . 1141
Shannon]. Drayton and Benjamin L. Weinstein
73. Anxiety Disorders 1: Generalized Anxiety,Panic, and Social Anxiety Disorders. . . . . . . . . . . 1161
Cynthia K. Kirkwoodand Sarah T. Melton
74. Anxiety Disorders 11:Posttraumatic Stress Disorderand Obsessive-Compulsive Disorder . . . . . . . . . . 1179
Cynthia K. Kirkwood, EugeneH. Makela,and Barbara G. Wells
75. Sleep Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1191
John M. Dopp and Bradley G. Phillips
76. Developmental Disabilities 1203
Nancy Brahm, Jerry McKee, and Robert C. Brown
SECTION 8
Endocrinologic OisordersSedion Editor: Robert L. Talbert
77. Diabetes Mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . 1205
Curtis L. Triplitt, Charles A. Reasner, 1I, and William L. Isley
78. Thyroid Disorders . . . . . . . . . . . . . . . . . . . . . . . . . 1243
Steven 1. Sherman and Robert L. Talbert
79. Adrenal Gland Disorders. . . . . . . . . . . . . . . . . . . . 1265
JohnG.Gums and Shawn Anderson
80. Pituitary Gland Disorders . . . . . . . . . . . . . . . . . . . 1281
Amy Heck Sheehan,JackA. Yanovski,and Karim Anton Calis
(9 The complete chapter, learningobjectives,and other resourcescan be found at www.pharmacotherapyonline.com.
SECTION 9
Gynecologic DisordersSection Editor: Barbara G. Wel/s
81. Pregnancy and Lactation:Therapeutic Considerations . . . . . . . . . . . . . . . . . 1297
Denise L. Walbrandt Pigarelli, Connie K. Kraus,and Beth E. Potter
82. Contraception 1313
Lori M. Dickerson, Sarah P. Shrader, and Vanessa A. Diaz
83. Menstruation-Related Disorders 1329
Elena M. Umland, Lara C. Weinstein, and Edward Buchanan
84. Endometriosis 1345
Deborah A. Sturpe
85. Hormone Therapy in Women .1351
Sophia N. Kalantaridou, SusanR. Davis, andKarim Anton Calis
SECTION 10
Urologic DisordersSection Editor: L. Michael Posey
86. Erectile Dysfunction. . . . . . . . . . . . . . . . . . . . . . . . 1369
Mary Lee
87. Management of BenignProstatic Hyperplasia. . . . . . . . . . . . . . . . . . . . . . . 1387
Mary Lee
88. Urinary Incontinence. . . . . . . . . . . . . . . . . . . . . . . 1399
Eric S.Rovner, lean Wyman, ThomasLackner,and David Guay
SECTION 11
ImmunologicDisordersSection Editor: Gary e Yee
89. Function and Evaluation of the
Immune System . 1417
Philip D. Hall andNicoleA. Weimert
90. SystemicLupus Erythematosus and OtherCollagen-Vascular Diseases 1431
leffrey c. Delafuente and Kimberly A. Cappuzzo
91. Allergic and Pseudoallergic Drug Reactions . . . . 1447
loseph T. DiPiro
92. Solid-Organ Transplantation . . . . . . . . . . . . . . . . 1459
Kristine S. Schonder and Heather l. lohnson
SECTION 12
Rheumatologic Disorders
SectionEditor:L. Michael Posey
93. Osteoporosisand OtherMetabolicBone Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1483
Mary Beth Q'Connell and Sheryl P. Vondracek
94. Rheumatoid Arthritis . . . . . . . . . . . . . . . . . . . . .. 1505
Arthur A. Schuna
95. Osteoarthritis 1519
Lucinda M. Buys and Mary Elizabeth Elliott
96. Gout and Hyperuricemia . . . . . . . . . . . . . . . . . .. 1539
Michael E. Ernst, Elizabeth C. Clark, and David W. Hawkins
SECTION 13
Ophthalmicand OtolaryngologicDisordersSection Editor: L. Michael Posey
97. Glaucoma 1551
Richard G. Piscella, Timothy S. Lesar, and Deepak P. Edward
98. AllergicRhinitis.. . . . . . . . . .. . . . . . . . . .. . . . .. 1565
l. Russell May and Philip H. Smith
SECTION 14
Dermatologic Disorders
SectionEditor:L.Michael Posey
99. Dermatologic Drug Reactions andSelf- Treatable Skin Disorders. . . . . . . . . . . . . . .. 1577
Nina H. Cheigh
100. Acne Vulgaris. . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1591
Dennis P. West, Amy Loyd, Kimberly A. Bauer, Lee E. West,
Laura Scuderi, and Giuseppe Micali
101. Psoriasis 1603
Dennis P. West, Amy Loyd, Lee E. West, Kimberly A. Bauer,
Maria Letizia Musumeci, and Giuseppe Micali
102. AtopicDermatitis. . .. . . . . . . . . . . . . . . .. .. . .. 1619
Nina H. Cheigh
SECTION 15
Hematologic Disorders
SectionEditor:Garye Yee103. Hematopoiesis 1627
William P. Petros and Michael Craig
104. Anemias.. . . . . . . . . . . .. . .. . . . . . . . . . . . . . . .. 1639
Beata A. Ineck, Barbara J. Mason, and Wi/liam L. Lyons
105. Coagulation Disorders . . . . . . . . . . . . . . . . . . . .. 1665
Betsy Bickert Poon and Char Witmer
106. Sickle Cell Disease. . . . . . . . . . . . . . . . . . . . . . . .. 1685
c. Y. Jennifer Chan and Reginald H. Moore
107. Drug-Induced Hematologic Disorders . . . . . . .. 1701
Dale H. Whitby and Thomas E. Johns
SECTION 16
InfectiousDiseases
Section Editor:Joseph T. DiPiro
108. Laboratory Tests to DirectAntimicrobial Pharmacotherapy . . . . . . . . . . . .. 1715
Michael J. Rybak and Jeffrey R. Aeschlimann
109. Antimicrobial Regimen Selection . . . . . . . . . . .. 1731
David S. Burgess
110. Central Nervous System Infections. . . . . . . . . .. 1743
Isaac F. Mitropoulos, Elizabeth D. Hermsen,
Jeremy A. Schafer, and John C. Rotschafer
111. LowerRespiratory Tract Infections. . . . . . . . . .. 1761Mark L. Glover and Michael D. Reed
112. Upper Respiratory Tract Infections. . . . . . . . . .. 1779
Yasmin Khaliq, SarahForgie,and GeorgeZhanel
113. Influenza . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1791
Elizabeth D. Hermsen and Mark E. Rupp
114. Skin and Soft-Tissue Infections. . . . . . . . . . . . .. 1801
Douglas N. Fish, Susan L. Pendland, and Larry H. Danziger
115. InfectiveEndocarditis. . . . . . . . . . . . . . . . . . . . .. 1821
Michael A. Crouch and Angie Veverka
116. Tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . .. 1839
Charles A. Peloquin
117. Gastrointestinal Infections and . . . . . . . . . . . . .. 1857
Enterotoxigenic Poisonings
Steven Martin and Rose Jung
118. Intraabdominal Infections . . . . . . . . . . . . . . . . .. 1875
JosephT. DiPiroand Thomas R. Howdieshell
119. Parasitic Diseases. . . . . . . . . . . . . . . . . . . . . . . ... 1887
J. V. Anandan
120. Urinary Tract Infections and Prostatitis. . . . . .. 1899
Elizabeth A. Coyle and Randall A. Prince
121. Sexually Transmitted Diseases 1915
Leroy C. Knodel
xi
122. Bone and Joint Infections . . . . . . . . . . . . . . . . . . . 1933
Edward P. Armstrong and Allan D. Friedman
123. Sepsisand Septic Shock. . . . . . . . . . . . . . . . . . . . . 1943
S. Lena Kang-Birken and Joseph T. DiPiro
124. Superficial Fungal Infections. . . . . . . . . . . . . . . . . 1957
Thomas E. R. Brown and Thomas W. F. Chin
125. Invasive Fungal Infections. .. .1973
Peggy L. Carver
126. Infections in Immunocompromised Patients . . .2003
Douglas N. Fish
127. Antimicrobial Prophylaxis in Surgery . . . . . . . . .2027Salmaan Kanji and John W. Devlin
128. Vaccines, Toxoids, andOther Immunobiologics . . . . . . . . . . . . . . . . . . . .2041
Mary S. Hayney
129. Human Immunodeficiency Virus Infection . . . .2065Peter L. Anderson, Thomas N. Kakuda,
and Courtney V. Fletcher
SECTION 17
Oncologic Disorders
SectionEditor:GaryC.Yee
130. CancerTreatmentand Chemotherapy.. . . . . . .2085Patrick J. Medina and Chris Fausel
131. Breast Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2121
Laura Boehnke Michaud, Janet L. Espirito,and Francisco J. Esteva
132. Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2157Jeannine S. McCune and Deborah A. Frieze
133. Colo rectal Cancer. . . . . . . . . . . . . . . . . . . . . . . . . .2175
Patrick J. Medina, Weijing Sun, and Lisa E. Davis
1 34. Prostate Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2207
Jill M. Kolesar
135. Lymphomas 2219
Val R. Adams and Gary C. Yee
136. Ovarian Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2245
Judith A. Smith and Judith K. Wolf
137. Acute Leukemias. . . . . . . . . . . . . . . . . . . . . . . . . . . 2259
Helen L. Leather and Betsy Bickert Poon
138. Chronic Leukemias . . . . . . . . . . . . . . . . . . . .2281
Amy M. Pick, Marce/ Devetten, and Timothy R. McGuire
139. Multiple Myeloma . . . . . . . . . . . . . . . . . . . . . . . . .2295
Timothy R. McGuire
140. Myelodysplastic Syndromes 4) . . . . . o. . . . . . . o2309
Julianna A. Burzynski and TrevorMcKibbin
14 1. Skin Cancer. . . .. o o . . o . . o . o o . o o . o . . o . . o . o o . 2311
Rowena N. Schwartz and Lindsay Jo Corporon
142. Hematopoietic Stem Cell Transplantation . . o. .2331
Janelle B. Perkins and Gary C. Yee
SECTION 18
Nutrition Disorders
Sedion Editor: Cory RoMotzke
143. Assessment ofNutrition Status and
Nutrition Requirements . o. . o. . o. . . . . . . o. . o. 2349
KatherineHammond Chessmanand Vanessa/. Kumpf
144. Prevalence and Significance of Malnutrition . . o 2367
GordonSacksand CatherineM. Crill
145. Parenteral Nutrition . . o. . o. . o. . . . . oo. . . . . o. 2379
Todd W. Mattox and Pamela DoReiter
146. Enteral Nutrition. o. . o. . o. . o. . o. . oo. . o. . o.. 2399
VanessaJoKumpf and KatherineHammond Chessman
147. Nutritional Considerations in MajorOrgan Failure o. oo. . . . . o . oo. . . . . . . . . o . . o. . o 2417
Brian Mo Hodges and Mark DeLegge
148. Obesity o. . o . . . . . o . . oo. . . . . o. oo. . o. . o . . . o. 2437
John Vo Sto Peter and Charles Jo Billington
Glossary . . . . o. oo. . . . . . . . oo. . . . . o. . o. . . . . . o. ooo. 2455
Index o o. . o. . . . . . . ooo. . o. . o. . o. . . . . oo. . oo.. 2481
top related